semaglutide compound update FDA Warns on Certain Forms of Compounded GLP-1 Weight Loss- Compounded Semaglutide

TLDR: GLP-1s are a massive, fast-growing drug class for type 2 diabetes and weight loss

As of early 2026, retatrutide is not yet FDA-approved for commercial use

Selective Agonism Rather than activating receptors fully, some experimental medications partially activate them or activate specific subtypes

Novo Nordisk reserves the right to modify or cancel these offers at any time

In response to a detailed list of questions, Lilly spokesperson Misty Fuller said the company does not comment on the specifics of individual compassionate use applications

Reddit threads and support groups are full of people describing feeling "flat" or "numb" going through the motions without feeling much of anything